Publications by authors named "Theodore Laetsch"

Claim this Profile
I
Infantile Fibrosarcoma of the Hand: Limb-Sparing Treatment With Modern Targeted Oral Chemotherapy and Conservative Surgical Resection.
John R Vaile, John A Tipps, Rachel Hurley, Sarah L Struble, Brooke E Allen, Theodore W Laetsch

J Hand Surg Glob Online· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors.
Matthew E Campbell, Sonja Stutzman, Sharon Primeaux, Deseray Sida, Minjae Lee, Theodore W Laetsch

Pediatr Blood Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare but not forgotten: Therapeutic advancements for rare childhood cancers.
Jacquelyn N Crane, Urania Dagalakis, Robyn D Gartrell, Kris Ann P Schultz, Theodore W Laetsch

Mol Ther Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant peripheral nerve sheath tumors: a report from children's oncology group study ARST0332.
Jacquelyn N Crane, Wei Xue, Amira Qumseya, Donald A Barkauskas, Khang Chau, Theodore W Laetsch

J Natl Cancer Inst· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Rare Pediatric Cancer Trial Enrollment: A Report From the Children's Oncology Group Rare Tumors Committee.
Brian R Englum, Jin Piao, Lindsay Younis, Reto M Baertschiger, Kenneth S Chen, Theodore W Laetsch

Pediatr Blood Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Safety and dosimetry of [Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.
Mark N Gaze, Daria Handkiewicz-Junak, Raquel Hladun, Theodore W Laetsch, Caryn Sorge

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating Pediatric Oncology Patients: The Emerging Role of Radioligand Therapy.
Theodore W Laetsch, Lisa J States, Margot A Lazow, Aman Chauhan

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating Multidisciplinary Care in Pediatric Thyroid Carcinoma: Insights From Children's Oncology Group Sites.
Casey Mehrhoff, Urania Dagalakis, Andrew J Bauer, Priya Mahajan, Theodore W Laetsch

Pediatr Blood Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel.
Swati Naik, Subodh Selukar, Aimee C Talleur, Samira Deshpande, Gabriela Llaurador Caraballo, Theodore W Laetsch

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and dosimetry of [Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.
Mark N Gaze, Daria Handkiewicz-Junak, Raquel Hladun, Theodore W Laetsch, Caryn Sorge

Eur J Nucl Med Mol Imaging· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liberalizing Hospital Proximity Requirements for Children/Young Adults with Low Burden B-ALL Receiving Tisagenlecleucel.
Lauren Elizabeth Appell, Christina Baggott, Khanh Nguyen, Snehit Prabhu, Holly L Pacenta, Theodore W Laetsch

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Two Punch: Combining Chemotherapy and Immunotherapy to Decrease Radiation Dose and Related Toxicity in Children and Adolescents with Nasopharyngeal Carcinoma.
Hetal Dholaria, Vera Tsetlina, Shae K Simpson, Emily Gillies, Nithyashri Eswaran, Theodore W Laetsch

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.
Jacquelyn N Crane, David P Douglass, Sapna Oberoi, Natalie B Collins, Ajay Gupta, Theodore W Laetsch

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adults.
Joseph Flores-Toro, Subhashini Jagu, Malcolm Smith, John Shern, Douglas S Hawkins, Theodore W Laetsch

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, Gregory K Friedman, James M Croop, Theodore W Laetsch

Pediatr Blood Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.
Sophie Leboulleux, Laura Boucai, Naifa Busaidy, Cosimo Durante, James A Fagin, Theodore W Laetsch

Lancet Diabetes Endocrinol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma.
Adeline T Yang, Sin-Ting Tiffany Lai, Theodore W Laetsch, Tricia Bhatti, Zubair Baloch

Endocr Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric Fusion-Positive Solid Tumors (Children's Oncology Group ADVL1823).
Theodore W Laetsch, Stephan Voss, Kathleen Ludwig, David Hall, Donald A Barkauskas

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of carcinomas among children and adolescents with birth defects.
Jeremy M Schraw, Ji Yun Tark, Tania A Desrosiers, Tiffany M Chambers, Charles J Shumate, Theodore W Laetsch

Cancer Epidemiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, Stefan Bielack, Daniel Orbach, Theodore W Laetsch

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composition and Priorities of Multidisciplinary Pediatric Thyroid Programs: A Consensus Statement.
Ronik Kothari, Julia R Donner, Karthik Balakrishnan, Gary Hartman, , Theodore W Laetsch

Thyroid· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, Stefan Bielack, Daniel Orbach, Theodore W Laetsch

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex pediatric neoplasms: The role of congenital cardiothoracic surgery.
Lindsay J Nitsche, Colleen E Bontrager, Paul J Devlin, Lea F Surrey, Jennifer E Pogoriler, Theodore W Laetsch

JTCVS Tech· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, Stefan Bielack, Daniel Orbach, Theodore W Laetsch

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.
Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani, Theodore W Laetsch

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis